Abstract
Dentofacial deformation is a common late adverse effect following radiotherapy for childhood head-and-neck tumours, yet current knowledge of dose-response relationships for developing facial bones and dental structures remains extremely limited. Age-adapted dose constraints and standardised clinical practices are lacking, complicating treatment optimisation and patient counselling. To address these critical gaps, we have established the SMILE consortium, a multi-disciplinary international collaboration of clinicians, scientists, and childhood cancer survivors. SMILE aims to establish structure-specific dose constraints, develop consensus guidelines including contouring atlases, and standardise follow-up protocols to minimise life-altering facial deformations and dental side-effects in future patients whilst better informing families.
| Original language | English |
|---|---|
| Article number | 100516 |
| Journal | 2730;2919;2735 |
| Volume | 7 |
| DOIs | |
| Publication status | Published - 1 Jun 2026 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Facial deformation
- Oral health
- Radiotherapy
Fingerprint
Dive into the research topics of 'Dentofacial side-effects in childhood cancer survivors: the SMILE consortium'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver